Tower Research Capital LLC (TRC) - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 265 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$37,317
-44.2%
2,840
-46.5%
0.00%
-50.0%
Q2 2023$66,906
+185750.0%
5,310
+95.0%
0.00%
+100.0%
Q1 2023$36
-14.3%
2,723
+13.8%
0.00%
-50.0%
Q4 2022$42
-100.0%
2,392
-86.0%
0.00%
-50.0%
Q3 2022$260,000
+150.0%
17,095
+144.8%
0.00%
+100.0%
Q2 2022$104,000
-42.2%
6,982
-12.5%
0.00%0.0%
Q1 2022$180,000
+181.2%
7,981
+129.7%
0.00%
+100.0%
Q4 2021$64,000
-83.1%
3,475
-87.7%
0.00%
-90.0%
Q3 2021$379,000
+553.4%
28,366
+803.1%
0.01%
+400.0%
Q2 2021$58,000
-71.8%
3,141
-77.2%
0.00%
-33.3%
Q1 2021$206,000
+32.1%
13,760
+27.3%
0.00%
-40.0%
Q4 2020$156,000
-91.9%
10,809
-95.4%
0.01%
-76.2%
Q3 2020$1,916,000
+329.6%
235,351
+257.3%
0.02%
+16.7%
Q2 2020$446,000
+5475.0%
65,871
+5647.9%
0.02%
Q1 2020$8,000
-92.9%
1,146
-90.0%
0.00%
-100.0%
Q4 2019$113,000
+707.1%
11,480
+781.0%
0.01%
+800.0%
Q3 2019$14,000
-87.6%
1,303
-86.6%
0.00%
-87.5%
Q2 2019$113,000
+79.4%
9,709
+46.2%
0.01%
+100.0%
Q1 2019$63,000
+200.0%
6,639
+212.9%
0.00%
+100.0%
Q4 2018$21,000
-91.8%
2,122
-88.1%
0.00%
-89.5%
Q3 2018$255,000
+722.6%
17,861
+580.9%
0.02%
+850.0%
Q2 2018$31,000
-58.7%
2,623
-56.7%
0.00%
-66.7%
Q1 2018$75,000
+400.0%
6,060
+496.5%
0.01%
+200.0%
Q4 2017$15,000
-96.9%
1,016
-97.0%
0.00%
-95.0%
Q3 2017$484,000
+3126.7%
34,046
+2804.9%
0.04%
+3900.0%
Q1 2017$15,000
-89.1%
1,172
-91.4%
0.00%
-93.3%
Q4 2016$138,000
+76.9%
13,584
+129.8%
0.02%
+87.5%
Q3 2016$78,000
+333.3%
5,912
+321.1%
0.01%
+300.0%
Q2 2016$18,000
-87.7%
1,404
-87.4%
0.00%
-90.9%
Q1 2016$146,000
+284.2%
11,103
+265.4%
0.02%
+450.0%
Q3 2015$38,000
+153.3%
3,039
+173.5%
0.00%
+300.0%
Q2 2015$15,000
-60.5%
1,111
-65.4%
0.00%
-80.0%
Q1 2015$38,000
-15.6%
3,215
-9.3%
0.01%
+25.0%
Q4 2014$45,000
-43.0%
3,544
-39.5%
0.00%
-55.6%
Q3 2014$79,000
-68.7%
5,856
-62.7%
0.01%
-71.9%
Q2 2014$252,000
+86.7%
15,690
+109.1%
0.03%
+88.2%
Q1 2014$135,000
+11.6%
7,502
-4.4%
0.02%
-15.0%
Q4 2013$121,000
-73.9%
7,846
-74.8%
0.02%
-60.0%
Q3 2013$463,000
+1222.9%
31,162
+1039.8%
0.05%
+1566.7%
Q2 2013$35,0002,7340.00%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q4 2017
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders